Search by Drug Name or NDC

    NDC 10019-0926-02 IFOSFAMIDE 3 g/60mL Details

    IFOSFAMIDE 3 g/60mL

    IFOSFAMIDE is a INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is IFOSFAMIDE.

    Product Information

    NDC 10019-0926
    Product ID 10019-926_4a719500-0f12-41cd-ac4c-5f50602d5b33
    Associated GPIs 21101025002130
    GCN Sequence Number 011781
    GCN Sequence Number Description ifosfamide VIAL 3 G INTRAVEN
    HIC3 V1A
    HIC3 Description ANTINEOPLASTIC - ALKYLATING AGENTS
    GCN 72722
    HICL Sequence Number 004570
    HICL Sequence Number Description IFOSFAMIDE
    Brand/Generic Generic
    Proprietary Name IFOSFAMIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name IFOSFAMIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 3
    Active Ingredient Units g/60mL
    Substance Name IFOSFAMIDE
    Labeler Name Baxter Healthcare Corporation
    Pharmaceutical Class Alkylating Activity [MoA], Alkylating Drug [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA019763
    Listing Certified Through 2024-12-31

    Package

    NDC 10019-0926-02 (10019092602)

    NDC Package Code 10019-926-02
    Billing NDC 10019092602
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-926-02) / 60 mL in 1 VIAL, SINGLE-DOSE (10019-926-16)
    Marketing Start Date 1988-12-30
    NDC Exclude Flag N
    Pricing Information N/A